2024 annual financial data

Emergent BioSolutions 2024 Net margin

Emergent BioSolutions 2024 net margin with verified reported values.

Direct answer

Net margin was -18.26%.

Operating income was -108,700,000 USD and net income was -190,600,000 USD.
Operating cash flow was 58,700,000 USD.

Get free Emergent BioSolutions email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,043,599,999 USD
Operating income
-108,700,000 USD
Net income
-190,600,000 USD
Operating cash flow
58,700,000 USD